Efficacy and safety of <scp>BNT162b2 mRNA</scp> vaccine in a cohort of 90 transfusion dependent thalassemia patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients

Published:2024-04-17 Issue:3 Volume:34 Page:238-240
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Medicine

Author:

Marziali M.¹,Pugliese P.¹,Losardo A. A.¹,Ribersani M.²,Anastasi E.³,Angeloni A.³,Pavan A.¹,Gentile G.⁴^ORCID

Affiliation:

1. Immunohematology and Transfusion Medicine Unit Policlinico Umberto I, Sapienza Università di Roma Rome Italy

2. Hematology Policlinico Umberto I, Sapienza Università di Roma Rome Italy

3. Department of Experimental Medicine Policlinico Umberto I, Sapienza Università di Roma Rome Italy

4. Department of Translational and Precision Medicine Sapienza Università di Roma Rome Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tme.13038

Reference10 articles.

1. Changing patterns in the epidemiology of β‐thalassemia

2. Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry

3. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection

4. Clinical outcome and humoral immune responses of β-thalassemia major patients with severe iron overload to SARS-CoV-2 infection and vaccination: a prospective cohort study

5. Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BNT162b2 mRNA vaccine in transfusion dependent thalassemia patients;Transfusion Medicine;2024-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3